Skip to main content
. Author manuscript; available in PMC: 2023 Jun 12.
Published in final edited form as: Sci Transl Med. 2023 May 3;15(694):eadg5562. doi: 10.1126/scitranslmed.adg5562

Table 1. Demographics and clinical details of case-control cohort.

NA, not applicable; DOL, day of life; NPO: non per os, no oral nutrition.

Cases Controls
Participants 19 37
Stools 210 252
Number of stools per participant before BSI (25th–75th quartile) 4 (3–6) 4 (2–4)
Number of stools per participant after BSI (25th–75th quartile) 6 (3–8) 3 (3–4)
Bacteremia DOL (25th–75th quartile) or matched DOL for controls 32 (20–44) 32 (19–46)
Antibiotic days before bacteremia or matched control DOL (25th–75th quartile) 16 (7–25) 21 (9–28)
Overall antibiotic score from birth to BSI or matched control DOL (25th–75th quartile) 53 (26–112) 57 (25–85)
Gestational age (25th–75th quartile) 25 (24–27) 25 (25–26)
Birthweight, g (25th–75th quartile) 740 (620–833) 810 (676–880)
% Female 68 68
% Cesarean 84 84
% First 8 weeks NPO 26 20
% First 8 weeks human milk 47 55
% First 8 weeks donor milk 6 7
% First 8 weeks formula 21 18
Bloodstream infection 19 NA
Staphylococcus aureus infection 6 NA
Streptococcus agalactiae 3 NA
Enterococcus faecalis 2 NA
Serratia marcescens 3 NA
Escherichia coli 2 NA
Klebsiella pneumoniae 2 NA
Enterobacter cloacae 1 NA